Similarly, 41 of 68 patients (60.3%) with intermediate activity NUDT15 diplotype in either donor or recipient cells also developed CMV infection despite ACV treatment (Fig. 5a). This evidence concerns the gene NUDT15 and cytomegalovirus infection.